617
Versican: a versatile extracellular matrix proteoglycan in cell biologyThomas N Wight
Versican is a large extracellular matrix proteoglycan that ispresent in a variety of tissues. Successful cloning of the genein man, mouse, cow and chicken has revealed the existence ofat least four splice variants of versican, which differ in the sizeof the core protein and the number of glycosaminoglycanchains. The highly interactive nature of versican provides a
basis for its importance as a structural molecule, creating looseand hydrated matrices during key events in development anddisease; and by interacting either directly with cells or
indirectly with molecules that associate with cells to, in part,regulate cell adhesion and survival, cell proliferation, cellmigration and extracellular matrix assembly. Several studieswithin the past two years have confirmed a significant role forversican in regulating cell phenotype.
Addresses
Department of Vascular Biology, The Hope Heart Institute,
1124Columbia Street, 7th Floor, Seattle, WA 98104-2046, USA; e-mail: TWight@hopeheart.org
Current Opinion in Cell Biology2002, 14:617–6230955-0674/02/$ — see front matter
© 2002 Elsevier Science Ltd. All rights reserved.DOI10.1016/S0955-0674(02)00375-7AbbreviationsECMextracellular matrixEGFepidermal growth factorG1globular domain 1G3globular domain 3GAGglycosaminoglycan
PDGFplatelet-derived growth factor TGF-β1transforming growth factor beta 1
Introduction
Versican belongs to the family of hyaluronan-binding proteoglycans that include aggrecan, neurocan and brevican, constituting a gene family collectively termed‘hyalectins’ [1,2 ]. These proteoglycans are componentsof the extracellular matrix (ECM) and are found in a largenumber of tissues. Each family member has a characteristicdistribution, with aggrecan prominent in cartilage, neuro-can and brevican prominent in the central nervous system(CNS), and versican present in a variety of soft tissues.The gene and protein structure of versican follows adomain template. The amino-terminal globular end (G1)binds to the glycosaminoglycan (GAG) hyaluronan, andthe carboxy-terminal globular domain (G3) resembles theselectin family of proteins, consisting of a C-type lectinadjacent to two epidermal growth factor (EGF) domainsand a complement regulatory region. The middle region ofthe versican core protein is encoded by two large exonsthat specify the chondroitin sulfate attachment regions ofversican. Combining the amino-terminal and carboxy-terminal features of versican with the GAGs attached tothe middle portion of the core protein reveals a highly
interactive and versatile molecule that is the basis for thename given to this all important macromolecule [3]. Considerable research since the discovery of versican hasrevealed not only a structural and biomechanical role forthis molecule in a variety of tissues, but also a cell biologicalrole influencing several cellular events that form the basisof development and disease. In this review, I will focus onthe role that versican plays in these cellular events.
Gene, protein and carbohydrate structure
The structure of versican was originally deduced by theanalysis of cDNA from a human placental library. It wasfound to be present as a large (i.e. 1–2×106Da) chon-droitin sulfate proteoglycan expressed by fibroblastsinvitro[3]. To date, the entire primary structures of versicanhave been generated from human [3,4], murine [5], bovine[6] and chick [7] cDNA clones. The chick form was originallynamed PG-M. In addition, partial cDNA sequences havebeen determined for the monkey homologue [8] and for aversican-like molecule in the salamander [9].
RNA splicing occurs in the two large exons encoding theGAG attachment sites. The region encoded by exon 7 iscalled αGAG, the region encoded by exon 8, βGAG [4].Four mRNA transcripts arise from alternative splicing, givingrise to V0, V1, V2 and V3 (reviewed in [2 ]). V0 possessesboth exon 7 and exon 8, V1 possesses exon 8 but not exon 7,V2 possesses exon 7 but not exon 8; and V3 possesses neither exon 7 nor exon 8. The consensus sequence forchondroitin sulfate attachment sites reveals the number ofpotential GAG attachment sites in human versican to be17–23 for V0, 12–15 for V1, 5–8 for V2, and 0 for V3.Typically, the attached chondroitin sulfate chains differ insize and composition, depending upon tissue of origin orculture conditions, or both. They can vary from 25–60kDaand contain different ratios of the chondroitin 6-sulfate tochondroitin 4-sulfate [10]. Since V3 contains no GAGattachment sites, it is predicted to be a glycoprotein andnot a proteoglycan and is sometimes affectionately referredto as ‘versicant’! (Figure 1). The expression of the versicangene (CSPG2) is regulated by a promoter that harbors atypical TATA box and potential binding sites for severaltranscription factors, including AP2, CCAAT enhancerprotein, and cAMP-responsive element.
Role in cell adhesion, proliferation, migrationand extracellular matrix assembly
Cell adhesion
Early studies show that versican is anti-adhesive [11–14],and this activity appears to reside in the G1 domain of versican [14,15]. However, the carboxy-terminal domain ofversican interacts with the β1 integrin of glioma cells, activating focal adhesion kinase (FAK), promoting cell
the extracellular matrix genes, and the cell ...proteoglycan-II, glypican, and a Miscellaneous DNA...Biology of polycystic kidney disease. Lab Invest ...
this versatile kinase also enhances the activity ...[19]; the extracellular matrix protein cartilage ...a predominate role for cAMP in granulosa cell ...
Corresponding author: Jody A. Rada, Department of Anatomy and Cell Biology,...Signi?cant changes in scleral extracellular matrix synthesis, accumulation, and...
and Chris Sander Computational Biology Center, ...in a highly versatile signalprocessing unit, able...cell migration, adhesion and extracellular matrix ...
and Chris Sander Computational Biology Center, ...in a highly versatile signalprocessing unit, able...cell migration, adhesion and extracellular matrix ...
热门文档